BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17526045)

  • 1. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
    Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
    Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
    Kim S; Lee YZ; Kim YS; Bahk YY
    Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
    Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteomic approach for dissecting H-Ras signaling networks in NIH/3T3 mouse embryonic fibroblast cells.
    Park JW; Kim S; Bahk YY
    Proteomics; 2006 Apr; 6(8):2433-43. PubMed ID: 16612794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteomic approach for unraveling the oncogenic H-Ras protein networks in NIH/3T3 mouse embryonic fibroblast cells.
    Park JW; Kim S; Lim KJ; Simpson RJ; Kim YS; Bahk YY
    Proteomics; 2006 Feb; 6(4):1175-86. PubMed ID: 16402364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
    Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
    Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes.
    Ji H; Erfani N; Tauro BJ; Kapp EA; Zhu HJ; Moritz RL; Lim JW; Simpson RJ
    Electrophoresis; 2008 Jun; 29(12):2660-71. PubMed ID: 18494037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proteomics approach to characterizing human submandibular gland cell lines by fluorescent two-dimensional differential in-gel electrophoresis.
    Kasamatsu A; Uzawa K; Nakashima D; Kouzu Y; Endo Y; Koike H; Yokoe H; Harada K; Sato M; Tanzawa H
    Int J Mol Med; 2006 Feb; 17(2):253-60. PubMed ID: 16391823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases.
    Varghese HJ; Davidson MT; MacDonald IC; Wilson SM; Nadkarni KV; Groom AC; Chambers AF
    Cancer Res; 2002 Feb; 62(3):887-91. PubMed ID: 11830548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
    Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
    Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-ras activation in vitro affects G1 and G2M cell-cycle transit times and apoptosis.
    Orecchia R; Infusini E; Sciutto A; Rapallo A; Di Vinci A; Nigro S; Geido E; Giaretti W
    J Pathol; 2000 Mar; 190(4):423-9. PubMed ID: 10699990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
    Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
    Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Par-4 by oncogenic Ras.
    Vasudevan KM; Ranganathan P; Rangnekar VM
    Methods Enzymol; 2006; 407():422-42. PubMed ID: 16757343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
    Takahashi N; De Luca LM; Breitman TR
    Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics analysis reveals insight into the mechanism of H-Ras-mediated transformation.
    Jin BF; He K; Wang HX; Bai B; Zhou T; Li HY; Man JH; Liu BY; Gong WL; Wang J; Li AL; Zhang XM
    J Proteome Res; 2006 Oct; 5(10):2815-23. PubMed ID: 17022653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
    Shumaker DK; Sklar MD; Prochownik EV; Varani J
    Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.